Evidence map›Paper›PMID 30971927›Full record

ArticleFrontiers in pharmacology2019

Evodiamine Augments NLRP3 Inflammasome Activation and Anti-bacterial Responses Through Inducing α-Tubulin Acetylation.

Chen-Guang Li, Qiong-Zhen Zeng, Ming-Ye Chen, Li-Hui Xu, Cheng-Cheng Zhang, Feng-Yi Mai, Chen-Ying Zeng, Xian-Hui He, Dong-Yun Ouyang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Chen-Guang LiDepartment of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Qiong-Zhen ZengDepartment of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Ming-Ye ChenDepartment of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Li-Hui XuDepartment of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Cheng-Cheng ZhangDepartment of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Feng-Yi MaiDepartment of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Chen-Ying ZengDepartment of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Xian-Hui HeDepartment of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Dong-Yun OuyangDepartment of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China.
Jinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evodiamine is a major ingredient of the plant

Indexed as

acetylationevodiamineNLRP3 inflammasomepyroptosisα-tubulin

Identifiers

PMID30971927
PMCPMC6443907
OpenAlexW2924866833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.